Summary
The properties of six adsorbents for Haemoperfusion were investigated in vitro: Amberlite XAD-2; Amberlite XAD-4; Haemocol; collodion coated charcoal; albumine-collodion encapsulated charcoal and activated carbon fibers. Carbromal and diazepam are most quickly removed from aqueous solutions by Amberlite XAD-2 and XAD-4. Of the charcoal containing materials, Haemocol eliminates most rapidly carbromal and diazepam; while activated carbon fibers remove phenobarbital faster. When heparinized blood is perfused, a remarkable reduction in platelet count is observed. The drop is most pronounced with Amberlite XAD-2 and XAD-4, but even when using charcoal preparations the platelet depletion can reach 10% of the original number over 5 hours. Haemolysis is most pronounced with Amberlite XAD-2, XAD-4 and Haemocol. As the efficiency of the adsorbents towards the various drugs differ and as their adverse effects also vary, the decision for a particular material will have to be made according to the individual case.
Zusammenfassung
In der vorliegenden Arbeit werden die Adsorptionseigenschaften von 6 verschiedenen Materialien, die bei der Hämoperfusion eingesetzt werden in vitro geprüft: Amberlite XAD-2 und XAD-4, Haemocol, Collodium verkapselte Aktivkohle, Collodium verkapselte und Albumin beschichtete Aktivkohle und Aktivkohle-Hohlfaser. Carbromal wird am schnellsten eliminiert von Amberlite XAD-2 und XAD-4, ebenso Diazepam. Beim Vergleich der verschiedenen Kohlepräparate werden Carbromal und Diazepam am schnellsten von Haemocol aus der Lösung entfernt, Phenobarbital von Aktivkohle-Hohlfaser, wenn man eine 5-stündige Perfusion zu Grunde legt. Die gerinnungsphysiologischen und klinisch-chemischen Untersuchungen mit Hilfe von heparinisiertem Frischblut lassen schwerwiegende Nebenwirkungen erkennen. Die Abnahme der Thrombozyten ist am ausgeprägtesten bei Amberlite XAD-2 und XAD-4, sie ist aber auch bei den Kohlepräparationen nachweisbar: Nach 5stündiger Hämoperfusion ist ihre Zahl auf bis zu 10% des Ausgangswertes abgefallen. Die Hämolyse ist besonders stark bei Amberlite XAD-2 und XAD-4, sowie Haemocol. Die je nach Giftstoff unterschiedlich große Adsorption der geprüften Materialien und ihre verschieden stark ausgeprägten Nebenwirkungen erfordern nach unseren Ergebnissen einen der individuellen Situation des Patienten angepaßten Einsatz.
Similar content being viewed by others
Literatur
Andrade, J. D., Kunitoma, K., van Wagenen, R., Kastigir, B., Gough, D., Kolff, W.J.: Coated adsorbents for direct blood perfusion: hema/activated carbon. Trans. Amer. Soc. Artif. Intern. Organs 17, 222 (1971)
Armstrong, C., Edwards, K.D.G.: Multifactorial design for testing oral ion exchange resins, charcoal and other factors in the treatment of aspirin poisoning in the rat. Efficacy of cholestyramine. Med. J. Aust.2, 301 (1967)
Babb, A.L., Popowich, R.P., Christopher, T.G., Scribner, B.H.: The genesis of the square meter-hour hypothesis. Trans. Amer. Soc. Artif. Intern. Organs17, 81 (1971)
Barakat, T., Mac Phee, I.W.: Experiments with an extracorporeal carbon column as a simplified artificial kidney. Br. J. Surg.57, 580 (1970)
Barakat, T., Mac Phee, I.W.: Bilirubin and alkaline phosphatase clearance from blood-plasma by perfusion through activated carbon. Br. J. Surg.58, 356 (1971)
Chang, T.M.S., Coffey, J.F., Lister, C., Taroy, E., Stark, A.: Methaqualone, methyprylone, and glutethimide clearance by the ACAC microcapsule artificial kidney: In vitro and in patients with acute intoxication. Trans. Amer. Soc. Artif. Intern. Organs19, 87 (1973)
Chang, T.M.S., Gonda, A., Dirks, J.H., Coffey, J.F., Leeburns, T.: ACAC microcapsule artificial kidney for the long term and short term management of eleven patients with chronic renal failure. Trans. Amer. Soc. Artif. Intern. Organs18, 465 (1972)
Chang, T.M.S., Gonda, A., Dirks, J.H., Malave, N.: Clinical evaluation of chronic, intermittent, and short term hemoperfusions in patients with chronic renal failure using membrane coated activated charcoal. Trans. Amer. Soc. Artif. Intern. Organs17, 246 (1971)
Chang, T.M.S., Johnson, L.J., Ransome, O.J.: Semipermeable aqueous microcapsules. IV. Nonthrombogenic microcapsules with heparin-complexed membranes. Can. J. Physiol. Pharmacol.45, 705 (1967)
Chang, T.M.S., Malave, N.: The development and first clinical use of semipermeable microcapsules (artificial cells) as a compact artificial kidney. Trans. Amer. Soc. Artif. Intern. Organs16, 141 (1970)
Chang, T.M.S., Pont, A., Johnson, L.J., Malave, N.: Response to intermittent extracorporeal perfusion through shunts containing semi-permeable microcapsules. Trans. Amer. Soc. Artif. Intern. Organs14, 163 (1968)
Davis, T.A., Cowsar, D.R., Harrison S.D. Jr., Tanquary, A.C.: Activated carbon fibers for hemoperfusion. Trans. Amer. Soc. Artif. Intern. Organs20, 353 (1974)
Decker, W.J., Combs, H.F., Treuting, J.J., Banez, R.J.: Dialysis of drugs against activated charcoal. Toxicol. Appl. Pharmacol.18, 573 (1971)
DeMyttenaere, M.H., Maher, J.F., Schreiner, G.E.: Hemoperfusion through a charcoal column for glutethimide poisoning. Trans. Amer. Soc. Artif. Intern. Organs13, 190 (1967)
Denti, E., Luboz, M.P., Tessore, V.: Adsorption characteristics of cellulose acetate coated charcoals. J. Biomed. Mater. Res.9, 143 (1975)
Dost, F.H.: Grundlagen der Pharmakokinetik, 2. Aufl., S. 311, Stuttgart: Verlag Georg Thieme, 1968
Dunea, G., Kolff, W.J.: Clinical experience with the Yatzidis charcoal artificial kidney. Trans. Amer. Soc. Artif. Intern. Organs11, 178 (1965)
Dunlop, E.H., Gazzard, B.G., Langley, P.G., Weston, M.J., Cox, L.R., Williams, R.: Design features of haemoperfusion columns containing activated charcoal. Med. Biol. Eng.14, 220 (1976)
Dutton, R.C., Dedrick, R.L., Bull, B.S.: A simple technique for the experimental production of acute platelet deficiency. Thromb. Diath. Haemorrh.21, 367 (1969)
Gazzard, B.G., Portmann, B., Weston, M.J., Langley, P.G., Murray-Lyon, J.J.M., Dunlop, E.H., Flax, H., Mellon, P.J., Record, C.D., Ward, M.B., Williams, R.: Charcoal haemoperfusion in the treatment of fulminant hepatic failure. Lancet,1, 1301 (1974)
Grabensee, B., Königshausen, T., Schnurr, E.: Behandlung schwerer Schlafmittelvergiftungen durch extracorporale Hämoperfusion. Dtsch. Med. Wochenschr.101, 158 (1976)
Hagstam, K.E., Larsson, L.E., Thysell, H.: Experimental studies on charcoal haemoperfusion in phenobarbital intoxication and uraemia, including histopathologic findings. Acta Med. Scand.180, 593 (1966)
Hennemann, H., Naujoks, R., Gattenlöhner, W., Röckel, A., Kaßler, G., Reiners, W., Heidland, A.: Hämoperfusion bei Schlafmittelvergiftungen. Dtsch. Med. Wochenschr.101, 155 (1976)
Kennedy, A.C., Briggs, J.D., Young, N., Lindsay, R.M., Luke, R.G., Campbell, D.: Successful treatment of three cases of severe barbiturate poisoning. Lancet1, 995 (1969)
Kisser, W.: Über den Nachweis und die quantitative Bestimmung bromierter Harnstoffderivate in der Toxikologie. Arch. Toxicol.22, 404 (1967)
Leber, H.W.: Anwendung der Haemoperfusion am Menschen. Wissenschaftliche Informationen der Fresenius-Stiftung4, 30 (1975)
Leber, H.W., Geißler, R.H., Faber, M., Post, D.: Experimentelle Untersuchungen zur Frage der Effektivität von Dialyse und Hämoperfusion bei Bromcarbamidintoxikationen. Klin. Wschr.54, 517 (1976)
Lesch, P., Blume, U., Scheibe, G., Sussmann, P., Schmidt, F.W., Barthels, M., Okonek, S.: Hameoperfusion durch verkapselte Aktivkohle zur Therapie exogener und endogener Intoxikationen. Klin. Wschr.54, 509 (1976)
Lie, T.S., Kim, W.J., Rommelsheim, K., Holst, A.: Behandlung von Koma-Patienten durch extrakorporale Hämoperfusion mit Aktivkohle. Münch. Med. Wochenschr.118, 945 (1976)
Lindsay, R.M., Prentice, C.R.M., Davidson, J.F., Burton, J.A., McNicol, G.P.: Haemostatic changes during dialysis associated with thrombus formation on dialysis membranes. Br. Med. J.4, 454 (1972)
Linton, A.L., Luke, R.G., Briggs, J.D., Kennedy, A.C.: Haemodialysis in the treatment of severe barbiturate intoxication. Proc. Europ. Dial. Transpl. Ass.4, 293 (1967). Excerpta Medica Foundation. International Congress Series No. 155.
Martin, A.M., Mitchell, D.C., Gibbins, J.K., Devapal, D., Trinder, P.: Charcoal haemoperfusion in the management of severe poisoning. Br. Med. J.1, 392 (1975)
Medd, R.K., Widdop, B., Braithwaite, R.A., Rees, A.J., Goulding, R.: Comparison of haemoperfusion and heamodialysis in the therapy of barbiturate intoxication in dogs. Arch. Toxicol.31, 163 (1973)
Nealon, T.F., Sugerman, H., Shea, W., Fleegler, E.: An extracorporeal device to treat barbiturate poisoning. Use of anionexchange resins in dogs. J. Am. Med. Assoc.197, 118 (1966)
Oellerich, M., Külpmann, W.R., Haeckel, R., Heyer, R.: Determination of phenobarbital and phenytoin in serum by a mechanised enzyme immunoassay (EMIT) in comparison with a gas-liquid chromatographic method. J. Clin. Chem. Clin. Biochem.15, 353 (1977)
Okonek, S.: Hämoperfusion mit beschichteter Aktivkohle zur Behandlung akuter Intoxikationen durch Arzneimittel, Pflanzenschutzmittel oder Pilze. I. Arzneimittel. Med. Klinik71, 1120 (1976)
Röckel, A., Schmid, G., Rupp, P., Kult, J., Hennemann, H., Heidland, A.: Hämoperfusion mit Aktivkohle und Ionenaustauscher bei phalloidinvergifteten Ratten. Dtsch. Med. Wochenschr.101, 418 (1976)
Rosenbaum, J.L., Mandanas, R.: Treatment of phenobarbital intoxication in dogs with an anion-recirculation peritoneal dialysis technique. Trans. Amer. Soc. Artif. Intern. Organs13, 183 (1967)
Rosenbaum, J.L., Ronquillo, E., Argyres, S.N.: Column haemoperfusion and haemodialysis techniques to treat barbiturate intoxication in dogs. J. Albert Einstein Med. Cent.16, 163 (1968)
Rosenbaum, J.L., Winsten, S., Kramer, M.S., Moros, J., Raja, R.: Resin haemoperfusion in the treatment of drug intoxication. Trans. Amer. Soc. Artif. Intern. Organs16, 134 (1970)
Schreiner, G.E.: The role of haemodialysis (artificial kidney) in acute poisoning. Arch. Intern. Med.102, 896 (1958)
Schreiner, G.E., Teehan, B.P.: Dialysis of poisons and drugsannual review. Trans. Amer. Soc. Artif. Intern. Organs18, 563 (1972)
Vale, J.A., Rees, A.J., Widdop, B., Goulding, R.: Use of charcoal haemoperfusion in the management of severely poisoned patients. Br. Med. J.1, 5 (1975)
Voigtmann, R., v. Baeyer, H., Sieberth, H.G.: Hämoperfusion über Aktivkohle — eine wesentliche therapeutische Bereicherung bei schweren Intoxikationen. Med. Welt27, 752 (1976)
Widdop, B., Medd, R.K., Braithwaite, R.A., Rees, A.J., Goulding, R.: Experimental drug intoxication: Treatment with charcoal haemoperfusion. Arch. Toxicol.34, 27 (1975)
Wieth, J.O.: Hemodialysis in barbiturate poisoning. Int. Anesthesiol. Clin.4, 359 (1966)
Yatzidis, H.: A convenient haemoperfusion microapparatus over charcoal for the treatment of endogenous and exogenous intoxications. Its use as an effective artificial kidney. Proc. Europ. Dial. Transpl. Ass.1, 83 (1964)
Yatzidis, H.: The use of ion exchange resins and charcoal in acute barbiturate poisoning. In “Acute barbiturate poisoning” (Hrsg. H. Matthew) S. 228 (1971). Amsterdam: Excerpta Medica
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Külpmann, W.R., Oellerich, M., Blume, U. et al. Vergleichende in vitro Untersuchungen zur Hämoperfusion mit verschiedenen Adsorbentien. Klin Wochenschr 56, 1171–1178 (1978). https://doi.org/10.1007/BF01476861
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01476861